BioNTech’s Lung Cancer Drug Shows Signs of a Major Breakthrough
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
Nyaribo said the campaign was a proactive measure to prevent FMD, which poses a threat to the livestock sector and farmers' livelihoods.
Shady surrogacy practices in the U.S. are raising concerns around mother-child safety and industry regulation, a CBS News investigation finds. Katrina Kaufman has more.
A recently-launched Medicare experiment that pays for technology to help people manage chronic conditions is expanding.
About 198 persons walk into the two facilities on the inaugural day and receive treatment
Patients with metastatic non-small cell lung cancer (NSCLC) harboring class II and class III BRAF alterations have distinct clinicopathologic and genomic characteristics, with class III alterations…
Experts explain the warning signs—and when it’s time to seek help.